Teradyne, Inc.

📈 Teradyne reported quarterly revenue of USD 1.33 billion, a massive 103.9% increase year-over-year that significantly beat analyst expectations of USD 1.22 billion.

💰 Earnings per share surged to USD 2.47, up from USD 0.57 in the prior year quarter, exceeding the consensus forecast of USD 2.09.

📊 The company achieved a net margin of 25.77% for the reported quarter, demonstrating strong operational efficiency and profitability growth.

🚀 Teradyne stock gained 4.49% in one session to reach USD 398.69, followed by six consecutive trading days of gains totaling a 21% rally.

💼 The market capitalization expanded to USD 62.33 billion as of September 23, 2026, reflecting investor confidence in the earnings beat.

📉 Despite the recent surge, shares remain below their 52-week high of USD 487.91 by approximately USD 89.22.

🚀 Teradyne reported Q2 2026 revenue of USD 1.33 billion, marking a 103.9% year-over-year increase.

💰 Earnings per share reached USD 2.47, beating analyst consensus of USD 2.09 by USD 0.38.

📈 Stock price closed at USD 371.47 on Nasdaq, rising 5.19% following the earnings announcement.

🔬 Company launched the Iris 100 MicroLED test system to capture demand in display and wearable markets.

🏆 Wall Street Zen upgraded Teradyne from hold to buy citing strong revenue acceleration.

🎯 Average analyst price target is USD 446.47, implying approximately 20% upside from current levels.

💼 Market capitalization stands at roughly USD 58.08 billion as of September 21, 2026.

🗓️ Teradyne is scheduled to present at the 2026 Goldman Sachs Communacopia + Technology Conference.

📊 Shares are among the notable 52-week gainers in the semiconductor equipment peer group.

🔍 Simply Wall St fair-value estimate of USD 442.20 suggests the stock is about 16% undervalued.

📈 Teradyne Inc. stock rose 5.2% to $371.47 on September 18, 2026, following a Wall Street Zen upgrade from Hold to Buy and a strong earnings beat.

💰 Revenue jumped 103.9% year over year to $1.33 billion in the quarter ended July 29, 2026, driven by robust demand for test equipment and automation.

📊 EPS reached $2.47, topping analyst consensus of $2.09 by $0.38 per share, highlighting strong operational momentum.

🏦 The company trades at a premium P/E ratio of 50.96 with a market capitalization of approximately $58.08 billion as of the September 18 close.

🎯 Analyst consensus stands at Moderate Buy with a price target of $396.80, suggesting roughly 6.8% upside from current levels.

👔 CEO Gregory Smith sold 4,000 shares under a pre-arranged Rule 10b5-1 trading plan, which is considered routine governance activity.

📅 The next earnings date is estimated for October 27, 2026, serving as the upcoming checkpoint for revenue and profit trajectory.

📉 Teradyne shares are currently positioned well above its 52-week low of $117.54 but remain below the 52-week high of $487.91.

📈 Teradyne Inc. stock climbed over 5 percent on September 18, 2026, closing at USD 371.47 as investors reacted to strong AI chip testing demand and India expansion.

💰 The company's market capitalization exceeded USD 58 billion, with shares rising approximately 92 percent year to date from a starting price of USD 193.56.

📊 Analyst consensus estimates for the quarter ending September 2026 project earnings per share of USD 2.03, representing a 138.82 percent increase over the same period last year.

🏢 Teradyne trades at a price-to-earnings ratio of 50.96 with a modest dividend yield of 0.14 percent, signaling premium valuation for its semiconductor and robotics exposure.

📉 Daily trading volume spiked to 4.29 million shares versus a 2.30 million average, indicating elevated investor interest during the recent rally.

🎯 The stock closed near the upper half of its 52-week range, which spans from USD 117.54 at the low to USD 487.91 at the high.

📈 Teradyne stock gained 4.3% on September 17, 2026, significantly outpacing the broader Nasdaq Composite's advance of roughly 1.7%.

🚀 The semiconductor rally lifted Teradyne alongside peers like Intel and Marvell Technology as investors rotated into chip-related exposure.

📊 Major U.S. equity indices including the S&P 500 and Dow Jones Industrial Average also closed higher, providing a supportive backdrop for equipment suppliers.

⏳ Investors are watching whether the prior day's momentum can carry over into the September 18 session as futures remain flat.

📉 Teradyne's near-term performance will likely depend on broader semiconductor sector flows and changes in sentiment around interest rates.

🔍 No specific company event was flagged for Teradyne on September 18, meaning the stock relies on general market conditions.

📈 Teradyne delivered a strong beat on Q2 revenue, exceeding analyst expectations driven by robust demand for AI testing solutions.

🚀 The company's stock has surged 72% year-to-date as investors react positively to its earnings performance and strategic focus on artificial intelligence.

📉 Despite the recent rally, Teradyne shares remain 31.8% below their 52-week high and are down 23% over the last three months.

🔮 Management provided positive guidance for the next quarter, citing sustained strong demand for its AI-related semiconductor testing products.

💡 The earnings report highlights Teradyne's successful adaptation to the evolving needs of the AI chip market, securing a key growth driver.

📈 Teradyne stock has returned approximately 185% over the past year following a business pivot toward AI data center testing equipment.

💰 In Q2 2026, more than 60% of Teradyne's revenue was generated from AI-driven testers for accelerators, CPUs, and memory technologies.

📉 Management guided non-GAAP operating margins to decline to 28%-30% in Q3 2026 due to a shift away from compute mix and rising expenses.

🚀 Teradyne shipped its first merchant GPU order in Q2 2026 and completed qualification at a second hyperscaler for future revenue growth.

📊 Analyst consensus forecasts 2027 earnings of $11.75 per share, which is higher than Teradyne's own internal target model range of $9.50-$11.

⚠️ The current stock price implies a forward multiple of roughly 36x for 2026 and 28.4x for 2027 based on analyst consensus earnings growth assumptions.

📈 Teradyne trades at $379.72 with analyst consensus and AI models projecting a fair value of $450.00.

🚀 Revenue surged by 103.9%, significantly outpacing the sector median of 24.1%.

💰 The company beat EPS estimates by 6.02% in its latest earnings report.

⚠️ Insiders have executed net sales of $13.2 million with no corresponding purchases.

📉 Valuation is elevated with a P/E ratio of 52.09 and P/S ratio of 13.30 versus sector averages.

📊 Technical indicators show neutral momentum with an RSI of 51 above the 50-day average.

📈 Teradyne Inc. shares rose 3.1% to $383.69 on September 9, 2026, trading near the average analyst target of $396.80 and below the Argus target of $422.00.

🤖 Company management confirmed that core businesses in semiconductor test, robotics, and product test are directly leveraged to AI infrastructure build-out from wafer probing to data center systems.

💰 Gross margins remain disciplined between 59% and 61%, with operating expenses growing at less than half the rate of revenue to generate significant operating leverage.

📊 Demand for high bandwidth memory (HBM) is expected to continue growing into 2027, supporting sustained test demand for related semiconductor devices in memory and logic production.

🎯 Analyst consensus rating is Moderate Buy with an average price target of $396.80, while Argus specifically targets $422.00 based on positive earnings trajectory views.

📉 Institutional ownership stands at 99.77%, dominated by professional investors including a quantitative fund that reduced its position by 42.8% in the second quarter.

📈 Long-term performance is strong, with $1,000 invested twenty years ago valued at over $26,500, representing an average annual return of 17.91% versus 8.77% for the broader market.

⚠️ Key risks include potential volatility in chipmaker capital spending affecting automated test equipment orders and competitive pressure in robotics and industrial automation markets.

📈 Teradyne Inc. shares trade at $356.50 with a market cap of $55.85 billion, reflecting strong investor demand for AI test instruments and robotics.

💰 The company reported record quarterly revenue of $1.33 billion, marking a 103.9% year-over-year increase driven by AI hardware testing needs.

📊 Teradyne achieved a net margin of 25.77% and a return on equity of 39.93%, demonstrating highly profitable operations in the latest quarter.

🎯 Analysts maintain a Moderate Buy rating with an average price target of $396.80, suggesting roughly 11.3% upside from current trading levels.

🏦 Wellington Management Group increased its Teradyne stake by 49.5% in Q2, acquiring over 17,000 additional shares valued at $25.6 million.

🤖 The company's Universal Robots brand provides collaborative robotic arms widely used in automotive and electronics manufacturing globally.

🔬 Teradyne develops high-precision test systems for validating advanced integrated circuits, including AI accelerators and high-performance processors.

💵 Teradyne declared a quarterly dividend of $0.13 per share, offering a yield of roughly 0.1% to signal confidence in cash flows.

📉 The stock trades at a P/E ratio near 48.98, priced below some fair value estimates around $442.20 according to Simply Wall St analysis.

🌍 Teradyne serves as a key vehicle for investors seeking exposure to global trends in chip testing and industrial automation.

📈 Teradyne stock is up 4.9% today following the launch of new UltraFLEXplus instruments for AI and data center semiconductor testing.

🚀 The company aims to strengthen its position across the AI device supply chain from wafer probe through final system validation.

💰 Teradyne reported record second-quarter 2026 revenue in late July with a third-quarter outlook reflecting robust AI-related demand.

🗓️ Management will appear at a major technology conference next week, potentially providing fresh commentary to support momentum.

🏦 Major institutional investors including JPMorgan Chase and Invesco added significant shares of TER to their portfolios in Q2 2026.

🎯 Wall Street analysts maintain a median price target of $443.0 for Teradyne, with targets ranging from $370 to $550.